Literature DB >> 15286374

Synthetic mammalian prions.

Giuseppe Legname1, Ilia V Baskakov, Hoang-Oanh B Nguyen, Detlev Riesner, Fred E Cohen, Stephen J DeArmond, Stanley B Prusiner.   

Abstract

Recombinant mouse prion protein (recMoPrP) produced in Escherichia coli was polymerized into amyloid fibrils that represent a subset of beta sheet-rich structures. Fibrils consisting of recMoPrP(89-230) were inoculated intracerebrally into transgenic (Tg) mice expressing MoPrP(89-231). The mice developed neurologic dysfunction between 380 and 660 days after inoculation. Brain extracts showed protease-resistant PrP by Western blotting; these extracts transmitted disease to wild-type FVB mice and Tg mice overexpressing PrP, with incubation times of 150 and 90 days, respectively. Neuropathological findings suggest that a novel prion strain was created. Our results provide compelling evidence that prions are infectious proteins.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15286374     DOI: 10.1126/science.1100195

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  371 in total

1.  Conformation-dependent high-affinity monoclonal antibodies to prion proteins.

Authors:  Larry H Stanker; Ana V Serban; Elisa Cleveland; Robert Hnasko; Azucena Lemus; Jiri Safar; Stephen J DeArmond; Stanley B Prusiner
Journal:  J Immunol       Date:  2010-06-07       Impact factor: 5.422

2.  Proper calibration of ultrasonic power enabled the quantitative analysis of the ultrasonication-induced amyloid formation process.

Authors:  Kei-ichi Yamaguchi; Tomoharu Matsumoto; Kazuo Kuwata
Journal:  Protein Sci       Date:  2011-11-22       Impact factor: 6.725

3.  Prion nucleation site unmasked by transient interaction with phospholipid cofactor.

Authors:  Ashley A Zurawel; Daniel J Walsh; Sean M Fortier; Tamutenda Chidawanyika; Suvrajit Sengupta; Kurt Zilm; Surachai Supattapone
Journal:  Biochemistry       Date:  2014-01-02       Impact factor: 3.162

4.  Dynamics of a truncated prion protein, PrP(113-231), from (15)N NMR relaxation: order parameters calculated and slow conformational fluctuations localized to a distinct region.

Authors:  Denis B D O'Sullivan; Christopher E Jones; Salama R Abdelraheim; Marcus W Brazier; Harold Toms; David R Brown; John H Viles
Journal:  Protein Sci       Date:  2009-02       Impact factor: 6.725

5.  The region approximately between amino acids 81 and 137 of proteinase K-resistant PrPSc is critical for the infectivity of the Chandler prion strain.

Authors:  Ryo Shindoh; Chan-Lan Kim; Chang-Hyun Song; Rie Hasebe; Motohiro Horiuchi
Journal:  J Virol       Date:  2009-01-28       Impact factor: 5.103

Review 6.  Getting a grip on prions: oligomers, amyloids, and pathological membrane interactions.

Authors:  Byron Caughey; Gerald S Baron; Bruce Chesebro; Martin Jeffrey
Journal:  Annu Rev Biochem       Date:  2009       Impact factor: 23.643

Review 7.  Insights into Mechanisms of Transmission and Pathogenesis from Transgenic Mouse Models of Prion Diseases.

Authors:  Julie A Moreno; Glenn C Telling
Journal:  Methods Mol Biol       Date:  2017

Review 8.  Prion diseases and their biochemical mechanisms.

Authors:  Nathan J Cobb; Witold K Surewicz
Journal:  Biochemistry       Date:  2009-03-31       Impact factor: 3.162

9.  A test for Creutzfeldt-Jakob disease using nasal brushings.

Authors:  Christina D Orrú; Matilde Bongianni; Giovanni Tonoli; Sergio Ferrari; Andrew G Hughson; Bradley R Groveman; Michele Fiorini; Maurizio Pocchiari; Salvatore Monaco; Byron Caughey; Gianluigi Zanusso
Journal:  N Engl J Med       Date:  2014-08-07       Impact factor: 91.245

10.  Novel epitopes identified by anti-PrP monoclonal antibodies produced following immunization of Prnp0/0 Balb/cJ mice with purified scrapie prions.

Authors:  Larry H Stanker; Miles C Scotcher; Alice Lin; Jeffery McGarvey; Stanley B Prusiner; Robert Hnasko
Journal:  Hybridoma (Larchmt)       Date:  2012-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.